0001179110-15-005202.txt : 20150318 0001179110-15-005202.hdr.sgml : 20150318 20150318192609 ACCESSION NUMBER: 0001179110-15-005202 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150317 FILED AS OF DATE: 20150318 DATE AS OF CHANGE: 20150318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rothera Mark CENTRAL INDEX KEY: 0001550424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 15711360 MAIL ADDRESS: STREET 1: C/O AEGERION PHARMACEUTICALS, INC. STREET 2: 101 MAIN STREET, SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2015-03-17 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001550424 Rothera Mark C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Commercial Officer Common Stock 2015-03-17 4 M 0 9450 10.85 A 9450 D Common Stock 2015-03-17 4 M 0 1250 10.85 A 10700 D Common Stock 2015-03-17 4 S 0 10700 76.64 D 0 D Stock Option (Right To Buy) 10.85 2015-03-17 4 M 0 9450 0 D 2023-05-15 Common Stock 9450 96875 D Stock Option (Right To Buy) 10.85 2015-03-17 4 M 0 1250 0 D 2023-05-15 Common Stock 1250 8125 D The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.35 to $76.88 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014. /s/ Colleen Diver Johnson, attorney-in-fact 2015-03-18